Synthesis, structural elucidation and pharmacological properties of some 5-acetyl-3,4-dihydro-6-methyl-4-(substituted phenyl)-2(1H)-pyrimidinones

Farmaco

Volumn 54, Issue 6, 1999, Pages 359-363

  Yarim, M ^a   Sarac S ^a   Ertan, M ^a   Batu, O ^b   Erol, K ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Calcium antagonistic activity; Synthesis UV, IR, 1H and 13C NMR and mass spectra; Tetrahydropyrimidine 2 ones

Indexed keywords

ACETYLACETONE; ALDEHYDE; BARIUM CHLORIDE; PYRIMIDINONE DERIVATIVE; UREA;

ANIMAL TISSUE; ARTICLE; CALCIUM ANTAGONISM; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; ILEUM CONTRACTION; INFRARED RADIATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; ULTRAVIOLET RADIATION;

ANIMALS; BARIUM COMPOUNDS; CALCIUM CHANNEL BLOCKERS; CHLORIDES; ILEUM; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MUSCLE RELAXATION; PYRIMIDINONES; RATS; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0033617999     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00042-7     Document Type: Article

References (13)

1. Bühler F.R., Hulthén U.L., Kiowski W., Muller F.B., Bolli P. The place of the calcium antagonist verapamil in antihypertensive therapy. J. Cardiovasc. Pharmacol. 4:1982;5350.
2. Theráux P., Taeymans Y., Waters D.D. Calcium antagonists. Clinical use in the treatment of angina. Drugs. 25:1983;178.
3. S. Cho, K. Shima, A. Mizuno, Y. Takeuchi, 4-Phenyl tetrahydropyrimidine-5-carboxylates, Jpn. Kokai Tokkyo Koho JP 61,130,276 [86,130,276] (Cl. C07D239/28), 18 June 1986; ref. CA 106 (1987) 5072s.
4. R. Vitolina, A. Kimenis, Effects of tetrahydropyrimidine derivatives on the cardiovascular system, Khim. Farm. Zh. 23 (1989) 285; ref. CA 111 (1989) 188c.
5. R. Vitolina, A. Kimenis, Effects of tetrahydropyrimidine derivatives on the cardiovascular system, Khim. Farm. Zh. 23 (1989) 285; ref. CA 111 (1989) 188c.
6. Ertan M., Balkan A., Saraç S., Uma S., Renaud J.F., Rolland Y. Synthesis and calcium antagonistic activity of some new 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives. Arch. Pharm. (Weinheim). 324:1991;135-139.
7. Ertan M., Balkan A., Saraç S., Uma S., Rübseman K., Renaud J.F. Synthesis and biological evaluations of some 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives. Arzneim. Forsch. Drug Res. 41:1991;725-727.
8. Y.F. Chi, Y.C. Ling, Pyrimidine research. Synthesis of 2-oxo-1,2,3,4-tetrahydro-pyrimidines. Reaction of acetylacetone and aldehydes with urea, Sci. Sin. (Peking) 6 (1957) 247-254; ref. CA 52 (1958) 396i.
9. Y.F. Chi, Y.C. Ling, Pyrimidine research. Synthesis of 2-oxo-1,2,3,4-tetrahydro-pyrimidines. Reaction of acetylacetone and aldehydes with urea, Sci. Sin. (Peking) 6 (1957) 247-254; ref. CA 52 (1958) 396i.
10. I. Toshio, N. Takashi, T. Yoshiho, M. Mitsuhiro, I. Shigeru, A. Hiroshi, I. Masayaku, Preparation of 5-acetyl-2-halo-4,6-disubstituted-pyrimidines as intermediates for antihypertensives, Jpn. Kokai Tokkyo Koho JP 03,07,265 [91,07,265] (Cl. C07D239/30), 14 Jan 91; ref. CA 114 (1991) 228948y.
11. Biginelli P. Ueber Aldehyduramide des Acetessigäthers. Chem. Ber. 24:1891;1317-1319.
12. Rose U., Dräger M. Synthesis, configuration and calcium modulatory properties of enantiomerically pure 5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylates. J. Med. Chem. 35:1992;2238-2243.
13. Kazda S., Garthoff B., Meyer H., Schloßmann K., Stoepel K., Towart R., Vater W., Wehinger E. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay K 5552). Arzneim. Forsch. Drug Res. 30:1980;2144-2162.